These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 11363719)

  • 1. Nipping HIV in the bud.
    Smart T
    GMHC Treat Issues; 1996 Aug; 10(8):3-6. PubMed ID: 11363719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on HIV protease inhibitors.
    Vella S
    AIDS Clin Care; 1995 Oct; 7(10):79-82, 88. PubMed ID: 11362832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New drugs for HIV infection.
    Med Lett Drugs Ther; 1996 Apr; 38(972):35-7. PubMed ID: 8606677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FDA triple header. Food and Drug Administration.
    Smart T
    GMHC Treat Issues; 1995 Nov; 9(11):1-3. PubMed ID: 11362986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protease inhibitors shine in triple combinations.
    AIDS Alert; 1996 Mar; 11(3):31-2. PubMed ID: 11363243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conference looks at HIV drug resistance.
    Chang HE
    GMHC Treat Issues; 1995 Sep; 9(9):6-8. PubMed ID: 11362910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protease inhibitors and prevention of cross resistance.
    Levin J
    AIDS Treat News; 1995 Oct; (no 232):1-3. PubMed ID: 11362875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3TC and saquinavir: we need them now.
    Baker R
    BETA; 1995 Sep; ():3. PubMed ID: 11362889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ritonavir: first to prolong survival.
    MacDougall DS
    J Int Assoc Physicians AIDS Care; 1996 Apr; 2(4):38-44. PubMed ID: 11363517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent new AIDS drugs underscore promise of combination therapy.
    AIDS Alert; 1996 Jan; 11(1):1-4. PubMed ID: 11363225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment for primary infection.
    Smart T
    GMHC Treat Issues; 1995 Dec; 9(12):1, 3-4. PubMed ID: 11362994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Which is the strategy? The latest in the use of antiretrovirals].
    Agosto M
    Sidahora; 1995; ():33-4. PubMed ID: 11363205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Merck protease inhibitor: more news from Retroviruses Conference.
    James JS
    AIDS Treat News; 1996 Feb; (no 241):1-3. PubMed ID: 11363186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on protease inhibitors.
    Cheng B
    PI Perspect; 1996 Apr; (no 18):5-7. PubMed ID: 11363512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abbott laboratories files New Drug Application for ritonavir.
    J Int Assoc Physicians AIDS Care; 1996 Jan; 2(1):35. PubMed ID: 11363329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Back to the nukes.
    Smart T
    GMHC Treat Issues; 1996 Feb; 10(2):6-7. PubMed ID: 11363383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ritonavir plus saquinavir: two trials with different results.
    Mascolini M
    AIDS Treat News; 1996 Sep; (No 254):5-6. PubMed ID: 11363819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protease inhibitors: ritonavir and saquinavir combination trial recruiting--seven U.S., Canada sites incl. San Francisco.
    AIDS Treat News; 1996 Apr; (no 245):1-3. PubMed ID: 11363621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ritonavir/saquinavir trial announced.
    J Int Assoc Physicians AIDS Care; 1996 Apr; 2(4):59. PubMed ID: 11363522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antiretroviral treatment in human immunodeficiency virus infection].
    Blum L; Bachmeyer C
    Ann Dermatol Venereol; 1997; 124(9):641-54. PubMed ID: 9739932
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.